Antimicrobial in Vitro Susceptibility of Actinomyces Israelii and Arachnia Propionica

References

• . Bach, M. C., Sabath, L. D. & Finland, M.: Susceptibility of Nocardia asteroides to 45 antimicrobial agents. Antimicrob Agents Chemother 3: 1, 1973.
   PubMed Web of Science ®Google Scholar
• . Bartlett, J. G., Sutter, V. L. & Finegold, S. M.: Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med 287: 1006, 1973.
   Web of Science ®Google Scholar
• . Blake, G. C.: Sensitivities of colonies and suspensions of Actinomyces israelii to penicillins, tetracyclines and erythromycin. Br Med J 1: 145, 1964.
   PubMedGoogle Scholar
• . Brock, D. W., Georg, L. K., Brown, J. M. & Hicklin, M.D.: Actinomycosis caused by Arachnia propionica. Am J Clin Pathol 59: 66, 1974.
   Web of Science ®Google Scholar
• . Cohen, L. E., McNeill, L. J. & Wells, R. F.: Clindamycin-associated colitis. JAMA 223: 1379, 1973.
   PubMed Web of Science ®Google Scholar
• . Coodley, E. L.: Actinomycosis: Clinical diagnosis and management. Postgrad Med 46: 73, 1969.
   PubMed Web of Science ®Google Scholar
• . Dobson, L. & Cutting, W. L.: Penicillin and sulfonamides in the therapy of actinomycosis. JAMA 128: 856, 1945.
   Web of Science ®Google Scholar
• . Dornbusch, K., Nord, C.-E. & Wadström, T.: Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis 6: 253, 1974.
   PubMed Web of Science ®Google Scholar
• . Dornbusch, K. & Nord, C.-E.: In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol (Berl) 160: 265, 1974.
   PubMed Web of Science ®Google Scholar
• . Dulbecco, R. & Vogt, M.: Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med 99: 167, 1954.
   PubMed Web of Science ®Google Scholar
• . Ericsson, H. M. & Sherris, J.: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand, Suppl. 217, 1971.
   Google Scholar
• . Finegold, S. M.: Antimicrobial therapy of anaerobic infections. Postgrad Med 58: 72, 1975.
   PubMed Web of Science ®Google Scholar
• . Garrod, L. P., Lambert, H. P. & O'Grady, F.: Antibiotic and chemotherapy. Churchill Livingstone, Edinburgh and London, 1971.
   Google Scholar
• . Georg, L. K.: Diagnostic procedures for the isolation and identification of the etiologic agents of actinomycosis. In: Proceedings Int. Symp. Mycoses, p. 71. WHO, Washington D.C. 1970
   Google Scholar
• . Georg, L. K. & Coleman, C. M.: Comparative pathogenicity of various Actinomyces species. In: The Actinomycetales, p. 35 (ed. H. Prauser). VEB Gustav Fischer Verlag, Jena 1970.
   Google Scholar
• . Green, L. W. & Black, W. C.: Treatment of cerviofacial actinomycosis with isoniazid. Rocky Mt Med J 52: 43, 1955.
   PubMedGoogle Scholar
• . Grove, D. C. & Randall, W. A.: Assay methods of antibiotics, a laboratory manual. Antibiot. monogr. No. 2. Medical Encyclopedia, New York 1955.
   Google Scholar
• . Heinrich, S. & Pulverer, G.: Zur Ätiologie und Mikrobiologie der Actinomycose. Zentralbl Bakteriol (Orig.) 176: 91, 1959.
   Google Scholar
• . Herrell, W. E., Balows, A. & Dailey, J. S.: Erythromycin in treatment of actinomycosis. Antibiot Med 2: 507, 1955.
   Google Scholar
• . Holdeman, L. V. & Moore, W. E. C.: Anaerobe laboratory manual, 2nd ed. Virginia Polytechnic Institute and State University, Blacksburg 1973.
   Google Scholar
• . Holm, P.: Studies on the etiology of human actinomycosis. I. The ‘other microbes’ of actinomycosis and their importance. Acta Pathol Microbiol Scand 27: 736, 1950.
   Google Scholar
• . Holm, P.: Studies on the etiology of actinomycosis. II. Do the ‘other microbes’ of actinomycosis possess virulence? Acta Pathol Microbiol Scand 28: 391, 1951.
   PubMedGoogle Scholar
• . Holmberg, K. & Nord, C.-E.: Numerical taxonomy and laboratory identification of Actinomyces and Arachnia and some related bacteria. J Gen Microbiol 91: 17, 1975.
   PubMedGoogle Scholar
• . Holmberg, K. & Forsum, U.: Identification of Actinomyces, Arachnia, Bacterionema, Rothia and Propionibacterium species by defined immunofluorescence. Appl Microbiol 25: 834, 1973.
   PubMedGoogle Scholar
• . Holmberg, K., Nord, C.-E. & Wadström, T.: Serological studies of Actinomyces israelii by crossed immunoelectrophoresis: taxonomic and diagnostic applications. Infect Immun 12: 398, 1975.
   PubMed Web of Science ®Google Scholar
• . Ings, R. M. J., McFadzean, J. A. & Ormerod, W. E.: The mode of action of metronidazole in Trichomonas vaginalis and other microorganisms. Biochem Pharmacol 23: 1421, 1974.
   PubMed Web of Science ®Google Scholar
• . Lane, S. L., Kutscher, A. H. & Chaves, R.: Oxytetracycline in the treatment of orocervical facial actinomycosis. JAMA 151: 986, 1953.
   PubMed Web of Science ®Google Scholar
• . Lerner, P. I.: Susceptibility of Actinomyces to cephalosporins and lincomycin. Antimicrob Agents Chemother 1967: 730, 1968.
   Google Scholar
• . Lerner, P. I.: Susceptibility of Actinomyces species to lincomycin and its 7-halogenated analogues. Antimicrob Agents Chemother 1968: 461, 1969.
   Google Scholar
• . Lerner, P. I.: Susceptibility of pathogenic actinomycetes to antimicrobial compounds. Antimicrob Agents Chemother 5: 302, 1974.
   PubMed Web of Science ®Google Scholar
• . McVay, L. V. Jr & Sprunt, D. H.: A long-term evaluation of aureomycin in the treatment of actinomycosis. Ann Intern Med 38: 955, 1953.
   PubMed Web of Science ®Google Scholar
• . McVay, L. V. Jr & Sprunt, D. H.: Treatment of actinomycosis with isoniazid. JAMA 153: 95, 1953.
   PubMed Web of Science ®Google Scholar
• . Mohr, J. A., Rhoades, E. R. & Muchmore, H. G.: Actinomycosis treated with lincomycin. JAMA 212: 2260, 1970.
   PubMed Web of Science ®Google Scholar
• . Peabody, J. W. Jr & Seabury, J. H.: Actinomycosis and nocardiosis. A review of basic differences in therapy. Am J Med 28: 99, 1960.
   PubMed Web of Science ®Google Scholar
• . Pine, L.: Classification and phylogenetic relationship of microaerophilic actinomycetes. Int Syst Bact 20: 445, 1970.
   Google Scholar
• . Prince, N. H., Brunberg, E., Titsworth, E. & DeLorenzo, W. F.: Effects of 1-(2-nitro-1-imadazolyl)-3-2-propanol and 2-methyl-5-nitroimidazole-1-ethanol against anaerobic and aerobic bacteria and protozoa. Appl Microbiol 18: 728, 1969.
   PubMedGoogle Scholar
• . Rose, H. D. & Rytel, M. W.: Actinomycosis treated with clindamycin. JAMA 221: 1052, 1972.
   PubMed Web of Science ®Google Scholar
• . Scott, A. J., Nicholson, G. I. & Kerr, A. R.: Lincomycin as a cause of pseudomembranous colitis. Lancet 2: 1232, 1973.
   PubMed Web of Science ®Google Scholar
• . Seabury, J. H. & Dascomb, H. E.: Results of the treatment of systemic mycoses. JAMA 188: 509, 1964.
   PubMed Web of Science ®Google Scholar
• . Steers, E., Foltz, E. L., Graves, B. S. & Rider, J.: An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot Chemother 9: 307, 1959.
   Google Scholar
• . Strauss, R. E., Kligman, A. M. & Pillsbury, D. M.: The chemotherapy of actinomycosis and nocardiosis. Am Rev Tuberc 63: 441, 1951.
   PubMedGoogle Scholar
• . Tally, F. P., Sutter, V. L. & Finegold, S. M.: Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother 7: 672, 1975.
   PubMed Web of Science ®Google Scholar
• . Torrens, J. A. & Wood, M. W. W.: Streptomycin in the treatment of actinomycosis. Lancet 1: 1091, 1949.
   PubMedGoogle Scholar
• . Viteri, A. L., Howard, P. H. & Dyck, W. P.: The spectrum of lincomycin-clindamycin colitis. Gastroenterology 66: 1137, 1974.
   PubMed Web of Science ®Google Scholar